The purpose of this study is to evaluate the safety and preliminary efficacy of low dose nicotine gel in patients with chronic diabetic ulcers
This pilot study will be the first time that nicotine will be applied directly onto the surface of chronic diabetic ulcer. The goals of the study are to evaluate safety and tolerability (particularly at the wound site) of a gel formulation containing low-dose nicotine, and to obtain preliminary information on its effects on accelerating wound closure. The study will be carried out on a background of conventional wound therapy in patients with Type II diabetes mellitus. Patients will be randomized to receive either study medication (ATG002), vehicle gel, or standard-of-care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
48
SeniorCare, Alabama Geriatric Specialists
Homewood, Alabama, United States
Hope Research Institute
Phoenix, Arizona, United States
Southern Arizona VA Health Care System
Tucson, Arizona, United States
Assessment of ulcer size as determined by weekly ulcer tracings
Assessment for complete wound closure. "Complete wound closure" will be defined as full epithelialization of the wound with the absence of drainage and lack of dressing requirement for an interval of at least 2 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Center for Clinical Research
Castro Valley, California, United States
University of San Diego Wound Treatment and Research Center
San Diego, California, United States
University of Miami
Miami, Florida, United States
Ankle and Foot Specialists of Atlanta
Lithonia, Georgia, United States
Crossroads Research, Inc.
Owings Mills, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
...and 3 more locations